These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20652862)

  • 1. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study.
    Johannes CB; Varas-Lorenzo C; McQuay LJ; Midkiff KD; Fife D
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):881-8. PubMed ID: 20652862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Serious Ventricular Arrhythmia in Users of Gastrointestinal Medications: A Retrospective Cohort Study in China.
    Zhang Y; Shu M; Liang W; Jiang K; Zhang D; Qiu H; Wu K
    Adv Ther; 2020 Apr; 37(4):1564-1578. PubMed ID: 32146705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
    Arana A; Johannes CB; McQuay LJ; Varas-Lorenzo C; Fife D; Rothman KJ
    Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.
    Chen HL; Hsiao FY
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):841-8. PubMed ID: 26098410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domperidone: ventricular arrhythmia and sudden death (continued).
    Prescrire Int; 2012 Jul; 21(129):183. PubMed ID: 22852288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domperidone: limited benefits with significant risk for sudden cardiac death.
    Hondeghem LM
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):218-25. PubMed ID: 23188128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domperidone and sudden death.
    Prescrire Int; 2006 Dec; 15(86):226. PubMed ID: 17167933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domperidone and long QT syndrome.
    Rossi M; Giorgi G
    Curr Drug Saf; 2010 Jul; 5(3):257-62. PubMed ID: 20394569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies.
    Ou LB; Moriello C; Douros A; Filion KB
    Br J Clin Pharmacol; 2021 Oct; 87(10):3649-3658. PubMed ID: 33439512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations.
    Buffery PJ; Strother RM
    N Z Med J; 2015 Jun; 128(1416):66-74. PubMed ID: 26117678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of domperidone on QT interval in neonates.
    Djeddi D; Kongolo G; Lefaix C; Mounard J; Léké A
    J Pediatr; 2008 Nov; 153(5):663-6. PubMed ID: 18589449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis.
    Leelakanok N; Holcombe A; Schweizer ML
    Clin Drug Investig; 2016 Feb; 36(2):97-107. PubMed ID: 26649742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands.
    van Noord C; Dieleman JP; van Herpen G; Verhamme K; Sturkenboom MC
    Drug Saf; 2010 Nov; 33(11):1003-14. PubMed ID: 20925438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological management of low milk supply with domperidone: separating fact from fiction.
    Grzeskowiak LE; Amir LH
    Med J Aust; 2014 Sep; 201(5):257-8. PubMed ID: 25163368
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
    Rochoy M; Auffret M; Béné J; Gautier S;
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):1-8. PubMed ID: 27988172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between domperidone and ventricular arrhythmia in the postpartum period.
    Smolina K; Mintzes B; Hanley GE; Oberlander TF; Morgan SG
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1210-1214. PubMed ID: 27296864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.
    Renoux C; Dell'Aniello S; Khairy P; Marras C; Bugden S; Turin TC; Blais L; Tamim H; Evans C; Steele R; Dormuth C; Ernst P;
    Br J Clin Pharmacol; 2016 Aug; 82(2):461-72. PubMed ID: 27062307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac adverse effects of domperidone in adult patients: a systematic review].
    Marzi M; Weitz D; Avila A; Molina G; Caraballo L; Piskulic L
    Rev Med Chil; 2015 Jan; 143(1):14-21. PubMed ID: 25860264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia.
    Prescrire Int; 2016 Oct; 25(175):238-240. PubMed ID: 30645828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.